文献速递脑血管病神经重症与神经感染

低血红蛋白与脑出血后血肿扩大相关

Low hemoglobin and hematoma expansion after intracerebral hemorrhage.
PubMed 文献 · Neurology · 2019-06-17

研究纳入2009至2016年单中心前瞻性ICH队列中256例有入院血红蛋白和神经影像数据的患者,发现较低血红蛋白水平与血肿扩大风险增高相关(OR 0.80每1.0 g/dL变化;95%CI 0.67-0.97),且血肿扩大介导了低血红蛋白与3个月不良结局的关联(p=0.01)。

要点

  • 入院血红蛋白每降低1.0 g/dL,血肿扩大风险增加20%(OR 0.80)。
  • 低血红蛋白与3个月不良结局相关(OR 0.76每1.0 g/dL变化)。
  • 血肿扩大介导了低血红蛋白与不良结局的关联(p=0.01)。

核心结论

  • 较低入院血红蛋白水平与脑出血后血肿扩大风险增高独立相关,且血肿扩大介导了低血红蛋白与更差3个月结局的关联。

研究设计与样本

  • 单中心前瞻性ICH队列研究,纳入2009至2016年连续患者,共256例符合标准。

主要发现

  • 256例中63例(25%)发生血肿扩大。
  • 调整血肿扩大和血红蛋白相关协变量后,血红蛋白每变化1.0 g/dL,血肿扩大OR为0.80(95%CI 0.67-0.97)。
  • 调整ICH评分后,血红蛋白每变化1.0 g/dL,3个月不良结局(mRS 4-6)OR为0.76(95%CI 0.62-0.94)。
  • 中介分析显示血肿扩大介导低血红蛋白与不良结局的关联(p=0.01)。

关键数值与推荐

  • 血肿扩大定义为体积增加>33%或>6 mL。
  • 不良结局定义为3个月mRS 4-6。

临床怎么用

  • 入院血红蛋白水平可能有助于识别血肿扩大和不良结局高风险的ICH患者。
  • 血红蛋白是否可作为可干预的治疗靶点尚需进一步研究确认。

局限性

  • 单中心研究,结果需外部验证。
  • 作者指出需进一步工作重复这些关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Studies have independently shown associations of lower hemoglobin levels with larger admission intracerebral hemorrhage (ICH) volumes and worse outcomes. We investigated whether lower admission hemoglobin levels are associated with more hematoma expansion (HE) after ICH and whether this mediates lower hemoglobin levels' association with worse outcomes. METHODS: Consecutive patients enrolled between 2009 and 2016 to a single-center prospective ICH cohort study with admission hemoglobin and neuroimaging data to calculate HE (>33% or >6 mL) were evaluated. The association of admission hemoglobin levels with HE and poor clinical outcomes using modified Rankin Scale (mRS 4-6) were assessed using separate multivariable logistic regression models. Mediation analysis investigated causal associations among hemoglobin, HE, and outcome. RESULTS: Of 256 patients with ICH meeting inclusion criteria, 63 (25%) had HE. Lower hemoglobin levels were associated with increased odds of HE (odds ratio [OR] 0.80 per 1.0 g/dL change of hemoglobin; 95% confidence interval [CI] 0.67-0.97) after adjusting for previously identified covariates of HE (admission hematoma volume, antithrombotic medication use, symptom onset to admission CT time) and hemoglobin (age, sex). Lower hemoglobin was also associated with worse 3-month outcomes (OR 0.76 per 1.0 g/dL change of hemoglobin; 95% CI 0.62-0.94) after adjusting for ICH score. Mediation analysis revealed that associations of lower hemoglobin with poor outcomes were mediated by HE (p = 0.01). CONCLUSIONS: Further work is required to replicate the associations of lower admission hemoglobin levels with increased odds of HE mediating worse outcomes after ICH. If confirmed, an investigation into whether hemoglobin levels can be a modifiable target of treatment to improve ICH outcomes may be warranted.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Roh DJ, Albers DJ, Magid-Bernstein J, et al. Low hemoglobin and hematoma expansion after intracerebral hemorrhage. Neurology. 2019. PMID: 31209179. doi:10.1212/WNL.0000000000007820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。